1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Exosome Diagnostic and Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 Instrument 1.2.3 Reagent 1.2.4 Software 1.3 Market by Application 1.3.1 Global Exosome Diagnostic and Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Cancer Institute 1.3.3 Hospital 1.3.4 Diagnostic Center 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Exosome Diagnostic and Therapeutic Market Perspective (2018-2029) 2.2 Exosome Diagnostic and Therapeutic Growth Trends by Region 2.2.1 Global Exosome Diagnostic and Therapeutic Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Exosome Diagnostic and Therapeutic Historic Market Size by Region (2018-2023) 2.2.3 Exosome Diagnostic and Therapeutic Forecasted Market Size by Region (2024-2029) 2.3 Exosome Diagnostic and Therapeutic Market Dynamics 2.3.1 Exosome Diagnostic and Therapeutic Industry Trends 2.3.2 Exosome Diagnostic and Therapeutic Market Drivers 2.3.3 Exosome Diagnostic and Therapeutic Market Challenges 2.3.4 Exosome Diagnostic and Therapeutic Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Exosome Diagnostic and Therapeutic Players by Revenue 3.1.1 Global Top Exosome Diagnostic and Therapeutic Players by Revenue (2018-2023) 3.1.2 Global Exosome Diagnostic and Therapeutic Revenue Market Share by Players (2018-2023) 3.2 Global Exosome Diagnostic and Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Exosome Diagnostic and Therapeutic Revenue 3.4 Global Exosome Diagnostic and Therapeutic Market Concentration Ratio 3.4.1 Global Exosome Diagnostic and Therapeutic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Exosome Diagnostic and Therapeutic Revenue in 2022 3.5 Exosome Diagnostic and Therapeutic Key Players Head office and Area Served 3.6 Key Players Exosome Diagnostic and Therapeutic Product Solution and Service 3.7 Date of Enter into Exosome Diagnostic and Therapeutic Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Exosome Diagnostic and Therapeutic Breakdown Data by Type 4.1 Global Exosome Diagnostic and Therapeutic Historic Market Size by Type (2018-2023) 4.2 Global Exosome Diagnostic and Therapeutic Forecasted Market Size by Type (2024-2029) 5 Exosome Diagnostic and Therapeutic Breakdown Data by Application 5.1 Global Exosome Diagnostic and Therapeutic Historic Market Size by Application (2018-2023) 5.2 Global Exosome Diagnostic and Therapeutic Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Exosome Diagnostic and Therapeutic Market Size (2018-2029) 6.2 North America Exosome Diagnostic and Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Exosome Diagnostic and Therapeutic Market Size by Country (2018-2023) 6.4 North America Exosome Diagnostic and Therapeutic Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Exosome Diagnostic and Therapeutic Market Size (2018-2029) 7.2 Europe Exosome Diagnostic and Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Exosome Diagnostic and Therapeutic Market Size by Country (2018-2023) 7.4 Europe Exosome Diagnostic and Therapeutic Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Exosome Diagnostic and Therapeutic Market Size (2018-2029) 8.2 Asia-Pacific Exosome Diagnostic and Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Exosome Diagnostic and Therapeutic Market Size by Region (2018-2023) 8.4 Asia-Pacific Exosome Diagnostic and Therapeutic Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Exosome Diagnostic and Therapeutic Market Size (2018-2029) 9.2 Latin America Exosome Diagnostic and Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Exosome Diagnostic and Therapeutic Market Size by Country (2018-2023) 9.4 Latin America Exosome Diagnostic and Therapeutic Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Exosome Diagnostic and Therapeutic Market Size (2018-2029) 10.2 Middle East & Africa Exosome Diagnostic and Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Exosome Diagnostic and Therapeutic Market Size by Country (2018-2023) 10.4 Middle East & Africa Exosome Diagnostic and Therapeutic Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 AMS Biotechnology 11.1.1 AMS Biotechnology Company Detail 11.1.2 AMS Biotechnology Business Overview 11.1.3 AMS Biotechnology Exosome Diagnostic and Therapeutic Introduction 11.1.4 AMS Biotechnology Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) 11.1.5 AMS Biotechnology Recent Development 11.2 ReNeuron 11.2.1 ReNeuron Company Detail 11.2.2 ReNeuron Business Overview 11.2.3 ReNeuron Exosome Diagnostic and Therapeutic Introduction 11.2.4 ReNeuron Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) 11.2.5 ReNeuron Recent Development 11.3 ExoCyte Therapeutics 11.3.1 ExoCyte Therapeutics Company Detail 11.3.2 ExoCyte Therapeutics Business Overview 11.3.3 ExoCyte Therapeutics Exosome Diagnostic and Therapeutic Introduction 11.3.4 ExoCyte Therapeutics Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) 11.3.5 ExoCyte Therapeutics Recent Development 11.4 Cell Guidance Systems 11.4.1 Cell Guidance Systems Company Detail 11.4.2 Cell Guidance Systems Business Overview 11.4.3 Cell Guidance Systems Exosome Diagnostic and Therapeutic Introduction 11.4.4 Cell Guidance Systems Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) 11.4.5 Cell Guidance Systems Recent Development 11.5 BioRegenerative Sciences 11.5.1 BioRegenerative Sciences Company Detail 11.5.2 BioRegenerative Sciences Business Overview 11.5.3 BioRegenerative Sciences Exosome Diagnostic and Therapeutic Introduction 11.5.4 BioRegenerative Sciences Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) 11.5.5 BioRegenerative Sciences Recent Development 11.6 Norgen Biotek 11.6.1 Norgen Biotek Company Detail 11.6.2 Norgen Biotek Business Overview 11.6.3 Norgen Biotek Exosome Diagnostic and Therapeutic Introduction 11.6.4 Norgen Biotek Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) 11.6.5 Norgen Biotek Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Exosome Diagnostic and Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of Instrument Table 3. Key Players of Reagent Table 4. Key Players of Software Table 5. Global Exosome Diagnostic and Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Exosome Diagnostic and Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 7. Global Exosome Diagnostic and Therapeutic Market Size by Region (2018-2023) & (US$ Million) Table 8. Global Exosome Diagnostic and Therapeutic Market Share by Region (2018-2023) Table 9. Global Exosome Diagnostic and Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 10. Global Exosome Diagnostic and Therapeutic Market Share by Region (2024-2029) Table 11. Exosome Diagnostic and Therapeutic Market Trends Table 12. Exosome Diagnostic and Therapeutic Market Drivers Table 13. Exosome Diagnostic and Therapeutic Market Challenges Table 14. Exosome Diagnostic and Therapeutic Market Restraints Table 15. Global Exosome Diagnostic and Therapeutic Revenue by Players (2018-2023) & (US$ Million) Table 16. Global Exosome Diagnostic and Therapeutic Market Share by Players (2018-2023) Table 17. Global Top Exosome Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostic and Therapeutic as of 2022) Table 18. Ranking of Global Top Exosome Diagnostic and Therapeutic Companies by Revenue (US$ Million) in 2022 Table 19. Global 5 Largest Players Market Share by Exosome Diagnostic and Therapeutic Revenue (CR5 and HHI) & (2018-2023) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Exosome Diagnostic and Therapeutic Product Solution and Service Table 22. Date of Enter into Exosome Diagnostic and Therapeutic Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Exosome Diagnostic and Therapeutic Market Size by Type (2018-2023) & (US$ Million) Table 25. Global Exosome Diagnostic and Therapeutic Revenue Market Share by Type (2018-2023) Table 26. Global Exosome Diagnostic and Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 27. Global Exosome Diagnostic and Therapeutic Revenue Market Share by Type (2024-2029) Table 28. Global Exosome Diagnostic and Therapeutic Market Size by Application (2018-2023) & (US$ Million) Table 29. Global Exosome Diagnostic and Therapeutic Revenue Market Share by Application (2018-2023) Table 30. Global Exosome Diagnostic and Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 31. Global Exosome Diagnostic and Therapeutic Revenue Market Share by Application (2024-2029) Table 32. North America Exosome Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 33. North America Exosome Diagnostic and Therapeutic Market Size by Country (2018-2023) & (US$ Million) Table 34. North America Exosome Diagnostic and Therapeutic Market Size by Country (2024-2029) & (US$ Million) Table 35. Europe Exosome Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 36. Europe Exosome Diagnostic and Therapeutic Market Size by Country (2018-2023) & (US$ Million) Table 37. Europe Exosome Diagnostic and Therapeutic Market Size by Country (2024-2029) & (US$ Million) Table 38. Asia-Pacific Exosome Diagnostic and Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 39. Asia-Pacific Exosome Diagnostic and Therapeutic Market Size by Region (2018-2023) & (US$ Million) Table 40. Asia-Pacific Exosome Diagnostic and Therapeutic Market Size by Region (2024-2029) & (US$ Million) Table 41. Latin America Exosome Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 42. Latin America Exosome Diagnostic and Therapeutic Market Size by Country (2018-2023) & (US$ Million) Table 43. Latin America Exosome Diagnostic and Therapeutic Market Size by Country (2024-2029) & (US$ Million) Table 44. Middle East & Africa Exosome Diagnostic and Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 45. Middle East & Africa Exosome Diagnostic and Therapeutic Market Size by Country (2018-2023) & (US$ Million) Table 46. Middle East & Africa Exosome Diagnostic and Therapeutic Market Size by Country (2024-2029) & (US$ Million) Table 47. AMS Biotechnology Company Detail Table 48. AMS Biotechnology Business Overview Table 49. AMS Biotechnology Exosome Diagnostic and Therapeutic Product Table 50. AMS Biotechnology Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) & (US$ Million) Table 51. AMS Biotechnology Recent Development Table 52. ReNeuron Company Detail Table 53. ReNeuron Business Overview Table 54. ReNeuron Exosome Diagnostic and Therapeutic Product Table 55. ReNeuron Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) & (US$ Million) Table 56. ReNeuron Recent Development Table 57. ExoCyte Therapeutics Company Detail Table 58. ExoCyte Therapeutics Business Overview Table 59. ExoCyte Therapeutics Exosome Diagnostic and Therapeutic Product Table 60. ExoCyte Therapeutics Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) & (US$ Million) Table 61. ExoCyte Therapeutics Recent Development Table 62. Cell Guidance Systems Company Detail Table 63. Cell Guidance Systems Business Overview Table 64. Cell Guidance Systems Exosome Diagnostic and Therapeutic Product Table 65. Cell Guidance Systems Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) & (US$ Million) Table 66. Cell Guidance Systems Recent Development Table 67. BioRegenerative Sciences Company Detail Table 68. BioRegenerative Sciences Business Overview Table 69. BioRegenerative Sciences Exosome Diagnostic and Therapeutic Product Table 70. BioRegenerative Sciences Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) & (US$ Million) Table 71. BioRegenerative Sciences Recent Development Table 72. Norgen Biotek Company Detail Table 73. Norgen Biotek Business Overview Table 74. Norgen Biotek Exosome Diagnostic and Therapeutic Product Table 75. Norgen Biotek Revenue in Exosome Diagnostic and Therapeutic Business (2018-2023) & (US$ Million) Table 76. Norgen Biotek Recent Development Table 77. Research Programs/Design for This Report Table 78. Key Data Information from Secondary Sources Table 79. Key Data Information from Primary Sources List of Figures Figure 1. Global Exosome Diagnostic and Therapeutic Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Exosome Diagnostic and Therapeutic Market Share by Type: 2022 VS 2029 Figure 3. Instrument Features Figure 4. Reagent Features Figure 5. Software Features Figure 6. Global Exosome Diagnostic and Therapeutic Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 7. Global Exosome Diagnostic and Therapeutic Market Share by Application: 2022 VS 2029 Figure 8. Cancer Institute Case Studies Figure 9. Hospital Case Studies Figure 10. Diagnostic Center Case Studies Figure 11. Others Case Studies Figure 12. Exosome Diagnostic and Therapeutic Report Years Considered Figure 13. Global Exosome Diagnostic and Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 14. Global Exosome Diagnostic and Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 15. Global Exosome Diagnostic and Therapeutic Market Share by Region: 2022 VS 2029 Figure 16. Global Exosome Diagnostic and Therapeutic Market Share by Players in 2022 Figure 17. Global Top Exosome Diagnostic and Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Diagnostic and Therapeutic as of 2022) Figure 18. The Top 10 and 5 Players Market Share by Exosome Diagnostic and Therapeutic Revenue in 2022 Figure 19. North America Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. North America Exosome Diagnostic and Therapeutic Market Share by Country (2018-2029) Figure 21. United States Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 22. Canada Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. Europe Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. Europe Exosome Diagnostic and Therapeutic Market Share by Country (2018-2029) Figure 25. Germany Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. France Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. U.K. Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Italy Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Russia Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 30. Nordic Countries Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Asia-Pacific Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. Asia-Pacific Exosome Diagnostic and Therapeutic Market Share by Region (2018-2029) Figure 33. China Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. Japan Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. South Korea Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Southeast Asia Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. India Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 38. Australia Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Latin America Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Latin America Exosome Diagnostic and Therapeutic Market Share by Country (2018-2029) Figure 41. Mexico Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 42. Brazil Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Middle East & Africa Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. Middle East & Africa Exosome Diagnostic and Therapeutic Market Share by Country (2018-2029) Figure 45. Turkey Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 46. Saudi Arabia Exosome Diagnostic and Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million) Figure 47. AMS Biotechnology Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2018-2023) Figure 48. ReNeuron Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2018-2023) Figure 49. ExoCyte Therapeutics Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2018-2023) Figure 50. Cell Guidance Systems Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2018-2023) Figure 51. BioRegenerative Sciences Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2018-2023) Figure 52. Norgen Biotek Revenue Growth Rate in Exosome Diagnostic and Therapeutic Business (2018-2023) Figure 53. Bottom-up and Top-down Approaches for This Report Figure 54. Data Triangulation Figure 55. Key Executives Interviewed

AMS Biotechnology ReNeuron ExoCyte Therapeutics Cell Guidance Systems BioRegenerative Sciences Norgen Biotek